Profil
Graeme Fraser is currently the Chief Scientific Officer at Ogeda SA. Previously, he worked as a Principal at AstraZeneca Canada, Inc. and Viron Therapeutics, Inc. He also served as the Vice President-Drug Discovery at Tranzyme Pharma, Inc. (Canada).
Dr. Fraser holds a doctorate degree from McGill University.
Postes actifs de Graeme Fraser
| Sociétés | Poste | Début |
|---|---|---|
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Graeme Fraser
| Sociétés | Poste | Fin |
|---|---|---|
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for inflammatory disorders | Corporate Officer/Principal | - |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations | Corporate Officer/Principal | - |
Tranzyme Pharma, Inc. (Canada) | Corporate Officer/Principal | - |
Formation de Graeme Fraser
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations | Health Technology |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for inflammatory disorders | Health Technology |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
Tranzyme Pharma, Inc. (Canada) |
















